Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,126
Closed -$179K 83
2023
Q3
$179K Sell
18,126
-2,892
-14% -$30.1K 0.12% 81
2023
Q2
$210K Buy
21,018
+137
+0.7% +$1.31K 0.14% 78
2023
Q1
$201K Sell
20,881
-1,169
-5% -$13K 0.15% 77
2022
Q4
$245K Buy
22,050
+131
+0.6% +$1.37K 0.19% 67
2022
Q3
$187K Sell
21,919
-345
-2% -$3.4K 0.16% 77
2022
Q2
$233K Sell
22,264
-659
-3% -$7.22K 0.19% 74
2022
Q1
$249K Sell
22,923
-1,579
-6% -$20.8K 0.17% 84
2021
Q4
$332K Sell
24,502
-32,088
-57% -$428K 0.22% 71
2021
Q3
$767K Sell
56,590
-1,731
-3% -$24.6K 0.56% 46
2021
Q2
$833K Sell
58,321
-3,475
-6% -$50.3K 0.6% 45
2021
Q1
$863K Buy
61,796
+23,936
+63% +$390K 0.64% 45
2020
Q4
$709K Buy
+37,860
New +$618K 0.57% 47

Other funds holding VTRS

Berkeley Inc's VTRS Position: Q4 2023 in Review

Berkeley Inc sold out of Viatris (VTRS) in Q4 2023, closing a stake of 18,126 shares — an estimated $179K sold.

Berkeley Inc first reported a position in VTRS in Q4 2020 and held it in 12 quarters. The position peaked at $863K in Q1 2021. 1,014 funds tracked by Wall St. Rank hold VTRS as of Q4 2023.

  • Berkeley Inc reported no remaining Viatris position as of Q4 2023 after selling out during the quarter.
  • Berkeley Inc sold 18,126 Viatris shares in Q4 2023, an estimated $179K.
  • Berkeley Inc first reported a position in Viatris in Q4 2020 and held it in 12 quarters.
  • Berkeley Inc's Viatris position peaked at $863K in Q1 2021.
  • 1,014 funds tracked by Wall St. Rank held Viatris as of Q4 2023.

Based on Berkeley Inc's 13F filing for Q4 2023, filed 4 Mar 2025.